Regular Article
Human Ingestion of Chromium (VI) in Drinking Water: Pharmacokinetics Following Repeated Exposure

https://doi.org/10.1006/taap.1996.7993Get rights and content

Abstract

Regulatory agencies have established safe drinking water concentrations for hexavalent chromium [Cr(VI)] based in part on the presumed capability of human gastric juices to rapidly reduce Cr(VI) to nontoxic trivalent chromium [Cr(III)] prior to systemic absorption. This study examines dose-related pharmacokinetics in humans following repeated oral exposure to Cr(VI) in drinking water. In particular, we sought to examine whether plausible drinking water exposures to Cr(VI) caused a sustained increase in red blood cell chromium levels, a specific marker for systemic uptake of Cr(VI). Adult male volunteers ingested a liter (in three volumes of 333 ml, at approximate 6-hr intervals) of deionized water containing Cr(VI) concentrations ranging from 0.1 to 10.0 mg/liter. Samples of urine, plasma, and red blood cells were collected and analyzed for chromium. A dose-related increase in urinary chromium excretion was observed in all volunteers. Red blood cell and plasma chromium concentrations became elevated in certain individuals at the highest doses. The RBC chromium profiles suggest that the ingested Cr(VI) was reduced to Cr(III) before entering the bloodstream, since the chromium concentration in the RBCs dropped rapidly postexposure. These findings suggest that the human gastrointestinal tract has the capacity to reduce ingested Cr(VI) following ingestion of up to 1 liter of water containing 10.0 mg/liter of Cr(VI), which is consistent with USEPA's position that the Cr(VI) drinking water standard of 0.10 mg Cr(VI)/liter is below the reductive capacity of the stomach.

References (0)

Cited by (50)

  • Lung function assessment and its association with blood chromium in a chromate exposed population

    2022, Science of the Total Environment
    Citation Excerpt :

    Considering spirometry is noninvasive and invaluable as a screening examination of general respiratory health, the reference value in present article may have significance to some extent; 3) Food pattern was not included as a covariate, and the source of blood Cr was not considered. However, several studies have shown that by observing the toxicokinetics of Cr(III) and Cr(VI) ingested by the human volunteers, soluble Cr(VI) compounds are absorbed to a greater extent than soluble Cr(III) compounds (Finley et al., 1997; Finley et al., 1996; Kerger et al., 1997; Kerger et al., 1996a; Kerger et al., 1996b; Paustenbach et al., 1996). Actually, we also roughly collected their dietary preferences and place of residence in questionnaire survey, which suggested that their dietary patterns were similar.

  • Chromium

    2021, Handbook on the Toxicology of Metals: Fifth Edition
  • Physiologically-based pharmacokinetic and toxicokinetic models for estimating human exposure to five toxic elements through oral ingestion

    2018, Environmental Toxicology and Pharmacology
    Citation Excerpt :

    It has been observed that human absorption of Cr(VI) in the GI tract can vary between individuals and also in the same individual at different times, with suggestions that physiological fluids in the GI tract such as gastric juice and diet constituents (for instance orange juice) can lead to poor intestinal absorption of Cr(VI), because of their capacities to reduce Cr(VI) to Cr(III) (De Flora et al., 1997; Kerger et al., 1996; Sasso and Schlosser, 2015). Intra-individual variability in Cr(VI) absorption due to differences in this reduction capacity has been noted in studies involving human subjects (Finley et al., 1997; Paustenbach et al., 1996; O’Flaherty et al., 2001). Absorption values of 0.25 day−1 for Cr(III) and 2.5 day−1 for Cr(VI) were specified by O’Flaherty et al. (2001).

View all citing articles on Scopus
View full text